glp-1 for mash Resmetirom and agonists MASH: complementary rather than exclusive GLP-1 therapies: a new frontier

It has a strong binding affinity for the ghrelin receptor

What you're left with isn't a weaker version of the original compoundit's a string of amino acids that no longer binds to receptors

Pancreatitis Risk: What the Evidence Actually Shows Pancreatitis was a concern raised in early post-marketing reports, leading the FDA to require labeling language across the class

Under the brand name Saxenda, the same molecule is FDA-approved for weight loss in adults and children ages 12 and older

Clin Obes 9:e12323 Stoll F, Kantowski T, Laaser J et al (2025) Tackling suboptimal clinical response after metabolic bariatric surgery: impact of Tirzepatide on weight loss and body composition